Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

109.36
-2.7300-2.44%
Volume:2.57M
Turnover:281.18M
Market Cap:136.04B
PE:23.12
High:111.49
Open:111.03
Low:108.73
Close:112.09
Loading ...

BRIEF-NY AG James- My Office And 48 AGS Secured $202 Million From Gilead Sciences - X Post

Reuters
·
1 hour ago

NY Ag James- My Office and 48 Ags Secured $202 Million From Gileadsciences - X Post

THOMSON REUTERS
·
1 hour ago

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-07-15

Reuters
·
Yesterday

Gilead Sciences and Arcus Biosciences: New Lung Cancer Treatment Combinations Under Evaluation

TIPRANKS
·
Yesterday

BUZZ-U.S. STOCKS ON THE MOVE-Aerospace firms, Tesla, natgas companies

Reuters
·
14 Jul

Gilead presents new data on twice-yearly lenacapavir for HIV prevention

TIPRANKS
·
14 Jul

Gilead Presents New Data on Twice-Yearly Lenacapavir (Yeztugo®) for Hiv Prevention at Ias 2025

THOMSON REUTERS
·
14 Jul

Gilead price target raised to $114 from $105 at Leerink

TIPRANKS
·
14 Jul

Gilead Sciences Secures FDA Approval for Yeztugo as HIV Prevention PrEP and Pursues Accelerated Regulatory Reviews Globally

Reuters
·
14 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Boeing, Crypto stocks, Kraft Heinz

Reuters
·
14 Jul

BUZZ-Leerink Partners raises PT on Gilead, citing HIV treatments prospects

Reuters
·
14 Jul

WHO recommends Gilead's twice-yearly injection for HIV prevention

Reuters
·
14 Jul

BRIEF-World Health Organization Recommends Injectable Lenacapavir For HIV Prevention

Reuters
·
14 Jul

Who Recommends Injectable Lenacapavir for Hiv Prevention

THOMSON REUTERS
·
14 Jul

World Health Organization: Recommends Public Health Approach to Hiv Testing Using Hiv Rapid Tests to Support Delivery of Long-Acting Injectable Prep

THOMSON REUTERS
·
14 Jul

Biotech Stocks Are Ready to Rebound. 3 to Watch Now. -- Barrons.com

Dow Jones
·
14 Jul

Gilead estimates Q2 acquired IPR&D expenses of $61M

TIPRANKS
·
12 Jul

Gilead Sciences Inc. Stock Slides 4.3%, Underperforms Competitors

Dow Jones
·
12 Jul

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-07-11

Reuters
·
11 Jul

BRIEF-Briacell’S Bria-Imt™ Demonstrates Survival Advantage Over Trodelvy® And Control Group In Metastatic Breast Cancer

Reuters
·
11 Jul